Evidence map›Paper›PMID 39127780›Full record

ArticleNature communications2024

On the origin of low-valent uranium oxidation state.

C L Silva, L Amidani, M Retegan, S Weiss, E F Bazarkina, T Graubner, F Kraus, K O Kvashnina

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Resolving the innerChemical science · 2026
    Article
  2. Article
  3. High-pressure synthesis of UCommunications chemistry · 2026
    Article
  4. Review
  5. Article
  6. Examining actinides with X-ray spectroscopy.Nature reviews. Chemistry · 2025
    Article
  7. Transient Covalency in Molten Uranium(III) Chloride.Journal of the American Chemical Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

C L SilvaThe Rossendorf Beamline at ESRF-The European Synchrotron, CS40220, 38043, Grenoble Cedex, France.ORCID http://orcid.org/0000-0002-4343-7638
L AmidaniThe Rossendorf Beamline at ESRF-The European Synchrotron, CS40220, 38043, Grenoble Cedex, France. lucia.amidani@esrf.fr.ORCID http://orcid.org/0000-0003-2234-4173
M ReteganEuropean Synchrotron Radiation Facility (ESRF), CS40220, 38043, Grenoble Cedex, France.ORCID http://orcid.org/0000-0002-1525-1094
S WeissHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Resource Ecology, 01314, Dresden, Germany.
E F BazarkinaThe Rossendorf Beamline at ESRF-The European Synchrotron, CS40220, 38043, Grenoble Cedex, France.
T GraubnerFachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Str. 4, 35032, Marburg, Germany.
F KrausFachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Str. 4, 35032, Marburg, Germany.ORCID http://orcid.org/0000-0003-4368-8418
K O KvashninaThe Rossendorf Beamline at ESRF-The European Synchrotron, CS40220, 38043, Grenoble Cedex, France. kristina.kvashnina@esrf.fr.ORCID http://orcid.org/0000-0003-4447-4542

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 759696
6 · The paper itself

Abstract

The significant interest in actinide bonding has recently focused on novel compounds with exotic oxidation states. However, the difficulty in obtaining relevant high-quality experimental data, particularly for low-valent actinide compounds, prevents a deeper understanding of 5f systems. Here we show X-ray absorption near-edge structure (XANES) measurements in the high-energy resolution fluorescence detection (HERFD) mode at the uranium M

Identifiers

PMID39127780
PMCPMC11316815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.